Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXU6GX
|
||||
| Drug Name |
3-(4-(2-methoxyphenyl)piperazin-1-yl)-1-phenylpropan-1-one oxime
|
||||
| Synonyms |
CHEMBL135669
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C20H25N3O2
|
||||
| Canonical SMILES |
COc1ccccc1N2CCN(CC\\C(=N/O)\\c3ccccc3)CC2
|
||||
| InChI |
InChI=1S/C20H25N3O2/c1-25-20-10-6-5-9-19(20)23-15-13-22(14-16-23)12-11-18(21-24)17-7-3-2-4-8-17/h2-10,24H,11-16H2,1H3/b21-18+
|
||||
| InChIKey |
ATWJQYZJOYHFBK-DYTRJAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.